Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain
Status:
Unknown status
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This study is a phase IV clinical trial with the objective of evaluating whether pain relief
associated with pregabalin for at-level non-evoked and evoked neuropathic pain is more
efficient during the early rather than late subacute phase of spinal cord injury.